Oryzon Genomics S.A.
Stock Forecast, Prediction & Price Target

Oryzon Genomics S.A. Financial Estimates

Oryzon Genomics S.A. Revenue Estimates

Oryzon Genomics S.A. EBITDA Estimates

Oryzon Genomics S.A. Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
€12.08M
 
N/A
€16.80M
 
39.12%
€15.66M
 
-6.79%
Avg: €1.90M
Low: €1.90M
High: €1.90M
avg. -87.83%
Avg: €4.02M
Low: €4.02M
High: €4.02M
avg. 111.02%
Avg: €259.11M
Low: €259.11M
High: €259.11M
avg. 6341.02%
Avg: €478.08M
Low: €478.08M
High: €478.08M
avg. 84.50%
Net Income
 
% change YoY
€-5.33M
 
N/A
€-4.53M
 
15.06%
€-3.70M
 
18.30%
Avg: €4.11M
Low: €4.11M
High: €4.11M
avg. 211.09%
Avg: €3.60M
Low: €3.60M
High: €3.60M
avg. -12.41%
Avg: €115.26M
Low: €115.26M
High: €115.26M
avg. 3100.51%
Avg: €210.05M
Low: €210.05M
High: €210.05M
avg. 82.23%
EBITDA
 
% change YoY
€-7.83M
 
N/A
€-5.72M
 
26.83%
€-4.89M
 
14.56%
Avg: €-854.82K
Low: €-854.82K
High: €-854.82K
avg. 82.53%
Avg: €-1.80M
Low: €-1.80M
High: €-1.80M
avg. -111.02%
Avg: €-116.18M
Low: €-116.18M
High: €-116.18M
avg. -6341.02%
Avg: €-214.37M
Low: €-214.37M
High: €-214.37M
avg. -84.50%
EPS
 
% change YoY
-$0.1
 
N/A
-$0.08
 
18.10%
-$0.06
 
25.76%
Avg: $0.07
Low: $0.07
High: $0.07
avg. 217.38%
Avg: $0.06
Low: $0.06
High: $0.06
avg. -12.41%
Avg: $2
Low: $2
High: $2
avg. 3100.51%
Avg: $3.65
Low: $3.65
High: $3.65
avg. 82.23%
Operating Expenses
 
% change YoY
€18.89M
 
N/A
€22.14M
 
17.22%
€20.42M
 
-7.79%
Avg: €663.94K
Low: €663.94K
High: €663.94K
avg. -96.74%
Avg: €1.40M
Low: €1.40M
High: €1.40M
avg. 111.02%
Avg: €90.24M
Low: €90.24M
High: €90.24M
avg. 6341.02%
Avg: €166.50M
Low: €166.50M
High: €166.50M
avg. 84.50%

FAQ

What is Oryzon Genomics S.A. stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 845.35% in 2025-2028.

We have gathered data from N/A analysts. Their low estimate is 4.11M, average is 4.11M and high is 4.11M.

What is Oryzon Genomics S.A. stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 1612.18% in 2025-2028.

We have gathered data from N/A analysts. Their low revenue estimate is €1.90M, average is €1.90M and high is €1.90M.

What is Oryzon Genomics S.A. stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 846.93% in 2025-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is $0.07, average is $0.07 and high is €0.07.